Suggested Topics within your search.
Showing 161 - 180 results of 2,042 for search '"peptide"', query time: 0.06s Refine Results
  1. 161
  2. 162
  3. 163

    Synthesis of Novel Peptide Dendrimers PDL-GB2 and PDL-G2 by Lin Yunzhu, Weng Lingling, Qi Qingrong

    Published 2015-01-01
    “…Peptide dendrimers are a novel type of macromolecules with precise structure, which can be used as drug target vector and controlled-release carrier. …”
    Get full text
    Article
  4. 164
  5. 165
  6. 166

    Peptide Design for Enhanced Anti-Melanogenesis: Optimizing Molecular Weight, Polarity, and Cyclization by Putri SA, Maharani R, Maksum IP, Siahaan TJ

    Published 2025-01-01
    “…It was found that optimal peptide size was within the range of 400– 600 Da. …”
    Get full text
    Article
  7. 167

    Dietary selenium peptide supplementation for increasing the growth of African catfish Clarias gariepinus by Muhammad Agus Suprayudi, Muhammad Roikhan Amanullah, Dedi Jusadi, Hasan Nasrullah, Ahmad Yazid Latif

    Published 2023-04-01
    “…The results showed that the final biomass of catfish fed with selenium peptide was significantly different (p<0.05) from catfish fed without selenium peptide, with a value of 1147,50 g and 96,67% of survival rate. …”
    Get full text
    Article
  8. 168
  9. 169
  10. 170

    In Vitro and In Vivo Characterization of Three Ga- and In-Labeled Peptides for Cholecystokinin Receptor Imaging by Susan Roosenburg, Peter Laverman, Lieke Joosten, Annemarie Eek, Floris P.J.T. Rutjes, Floris L. van Delft, Otto C. Boerman

    Published 2012-09-01
    “…On PET/computed tomographic (CT) and SPECT/CT scans, subcutaneous A431-CCK2R tumors were clearly visualized with low uptake of sCCK8 peptides in the intestines. Whereas radiolabeled DOTA-MG0 showed high kidney uptake (70% ID/g), the sCCK8 peptides showed low uptake in the kidneys. …”
    Get full text
    Article
  11. 171
  12. 172

    Case report: Resolution of VIPoma-related symptoms with peptide receptor radionuclide therapy by Turgut Bora Cengiz, Raksha Kulkarni, Virginia Corbett, Nasrin V. Ghesani, Edward Wolin, Munir V. Ghesani

    Published 2025-01-01
    “…Peptide receptor radionuclide therapy (PRRT) is used for the management of neuroendocrine tumors (NETs) not responsive to somatostatin analogs. …”
    Get full text
    Article
  13. 173
  14. 174

    C-Peptide Levels Predict the Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Therapy by Sevin Demir, Sule Temizkan, Mehmet Sargin

    Published 2016-01-01
    “…These effects depend on baseline C-peptide levels.…”
    Get full text
    Article
  15. 175
  16. 176

    Secretory Leukocyte Protease Inhibitor Is an Inducible Antimicrobial Peptide Expressed in Staphylococcus aureus Endophthalmitis by Victor E. Reviglio, Ruben H. Sambuelli, Alejandra Olmedo, Micaela Falco, Jose Echenique, Terrence P. O'Brien, Irene C. Kuo

    Published 2007-01-01
    “…To describe the presence of secretory leukocyte protease inhibitor (SLPI), a cationic peptide with antimicrobial and antiprotease activity, in the innate ocular immune reaction in a rat model of Staphylococcus aureus endophthalmitis. …”
    Get full text
    Article
  17. 177

    Significance of N-terminal pro-B-type natriuretic peptide levels in lung cancer by Sinem İnan, Semra Bilaçeroğlu, Burcu Uludağ Artun

    Published 2025-01-01
    Subjects: “…N-terminal pro-brain natriuretic peptide…”
    Get full text
    Article
  18. 178

    Evaluation of the effectiveness of a peptide-cytokine agent in the complex therapy of recurrent candidal vulvovaginitis by Elena A. Rosyuk

    Published 2024-12-01
    “…To evaluate the effectiveness of the peptide-cytokine agent Superlymph in the complex therapy of recurrent CVV. …”
    Get full text
    Article
  19. 179
  20. 180

    A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy by Youmei Xiao, Zhuoying He, Wanqiong Li, Danhong Chen, Xiaoshuang Niu, Xin Yang, Wenxuan Zeng, Mengfan Wang, Yuzhen Qian, Ye Su, Feiyu Luo, Guanyu Chen, Juan Liu, Xinghua Sui, Xiuman Zhou, Yanfeng Gao

    Published 2025-02-01
    “…As a proof-of-concept, this study introduces a modular TFRC-based covalent peptide degradation platform for the degradation of membrane protein, and especially for the immunotherapy of brain tumors.…”
    Get full text
    Article